SAB Biotherapeutics SABS Q1 2025 Annual earnings

FAQ

When did SAB Biotherapeutics report Q1 2025 earnings?

SAB Biotherapeutics (SABS) reported Q1 2025 earnings on May 9, 2025 before market open.

What were SAB Biotherapeutics's Q1 2025 revenue and EPS?

SAB Biotherapeutics reported eps of $-0.56 for Q1 2025.

Did SAB Biotherapeutics beat estimates in Q1 2025?

EPS beat the consensus estimate of $-1.00 by $0.44.

How did SAB Biotherapeutics's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 3.7% from $-0.54.

Where can I find SAB Biotherapeutics's Q1 2025 SEC filings?

You can read the 10-K periodic report (0000950170-25-046994) directly on SEC EDGAR. The filing index links above go to sec.gov.